Patient Guide: A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 30 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05298254
Status: ACTIVE_NOT_RECRUITING
Condition: Herpes Simplex
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 30 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Phoenix, Arizona
  • Wichita, Kansas
  • Kansas City, Missouri
  • • And 27 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily